Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous n-3 polyunsaturated fatty acids on risk markers for sudden cardiac death in hemodialysis patients
2005-002380-90Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in chronic kidney disease (CKD) and sudden cardiac death (SCD), sponsored by Aalborg University Hospital. Primary endpoint: Effect on heart rate variability and arrhythmias. Started Aug 2005; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
chronic kidney disease (CKD)sudden cardiac death (SCD)
Beyond the preview
Go deeper on 2005-002380-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002380-90.